|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
1/18/2013 7:57:08 AM
Columbia Laboratories Inc. (Nasdaq: CBRX), a maker of topical hormone products, plans to relocate operations to the Boston area to accommodate the company’s CEO and newly hired CFO, who live in the area. The company currently has about 12 employees at its current headquarters in Livingston, New Jersey. Columbia Labs will be looking to make some hires in the Boston-area, because some of the workers have chosen not to move with the headquarters. The company is still considering “several attractive pieces of real estate”, according to spokeswoman Amy Raskopf, and has not made up its mind about whether to locate in Boston, Cambridge or a more far-flung suburb. CEO Frank Condella has been commuting back and forth from Massachusetts to New Jersey for three years, and the company just hired CFO Jonathan Lloyd Jones, another local resident, who previously served in management positions at Cambridge, Mass.-based Genzyme Corp. and two privately-held biotechnology firms.
|
|
|
|
|
|
|
|
|
|
|